Cortical Synaptic Density is Reduced in Mild to Moderate Human Immunodeficiency Virus Neurocognitive Disorder

Dendritic and synaptic damage (without frank neuronal loss) may be seen in milder human immunodeficiency virus (HIV)‐related cognitive disorders. Synapse volume estimates, performed by stereological methods, could enhance the ability to detect subtle neuronal changes that may accompany cognitive impairment in HIV infection. For the present study, synaptic density and neuronal number were assessed by combined stereology/confocal microscopy and these measures were then correlated with ante‐mortem levels of cognitive performance in AIDS patients. Three‐dimensional stereological measures showed a significant correlation between reduced synaptic density and poor neuropsychological performance. To evaluate the specificity of any observed associations, additional variables including viral burden, astrogliosis and number of calbindin‐immunoreactive neurons were measured. Factor analysis of a set of neuropathological variables revealed two factors; one defined by synaptic density and volume fraction, calbindin pyramidal neuronal densities and viral burden; the second by astrocytosis and calbindin interneuron density. Only the first factor correlated significantly with neuropsychological functioning during life.

[1]  R. DeTeresa,et al.  Neocortical cell counts in normal human adult aging , 1987, Annals of neurology.

[2]  S. Lipton,et al.  HIV-1 coat protein neurotoxicity prevented by calcium channel antagonists. , 1990, Science.

[3]  P. Lantos,et al.  HIV‐Associated Disease of the Nervous System: Review of Nomenclature and Proposal for Neuropathology‐Based Terminology , 1991, Brain pathology.

[4]  P. Lantos,et al.  Neuronal loss in the frontal cortex in HIV infection , 1991, The Lancet.

[5]  E. Masliah,et al.  Neocortical damage during HIV infection , 1991, Annals of neurology.

[6]  Andrew J. Saykin,et al.  Nomenclature and research case definitions for neurologic manifestations of human immunodeficiency virus‐type 1 (HIV‐1) infection , 1991, Neurology.

[7]  C. Achim,et al.  Selective Neuronal Vulnerability in HIV Encephalitis , 1992, Journal of neuropathology and experimental neurology.

[8]  P. Lantos,et al.  Neuronal loss in symptom-free HIV infection , 1992, The Lancet.

[9]  E. Masliah,et al.  Spectrum of human immunodeficiency virus–associated neocortical damage , 1992, Annals of neurology.

[10]  P. Lantos,et al.  Neuronal number and volume alterations in the neocortex of HIV infected individuals. , 1993, Journal of neurology, neurosurgery, and psychiatry.

[11]  I Grant,et al.  Neuropsychological impairment in human immunodeficiency virus‐infection: implications for employment. HNRC Group. HIV Neurobehavioral Research Center. , 1994, Psychosomatic medicine.

[12]  M. Louder,et al.  Overexpression of nef as a marker for restricted HIV‐1 infection of astrocytes in postmortem pediatric central nervous tissues , 1994, Neurology.

[13]  E. Masliah,et al.  Cytokine receptor alterations during HIV infection in the human central nervous system , 1994, Brain Research.

[14]  C. Achim,et al.  Human immunodeficiency virus encephalitis is the pathological correlate of dementia in acquired immunodeficiency syndrome , 1994, Annals of neurology.

[15]  C. Achim,et al.  Brain Viral Burden in HIV Infection , 1994, Journal of neuropathology and experimental neurology.

[16]  L. Mucke,et al.  Central nervous system damage produced by expression of the HIV-1 coat protein gp120 in transgenic mice. , 1994, Nature.

[17]  E. Masliah,et al.  Differential Vulnerability of Calbindin‐immunoreactive Neurons in HIV Encephalitis , 1995, Journal of neuropathology and experimental neurology.

[18]  Michael J. Taylor,et al.  The HNRC 500-Neuropsychology of Hiv infection at different disease stages , 1995, Journal of the International Neuropsychological Society.

[19]  D. Rusyniak,et al.  HIV-1 gp120-induced neurotoxicity to midbrain dopamine cultures , 1995, Brain Research.

[20]  J. Glass,et al.  Immunocytochemical quantitation of human immunodeficiency virus in the brain: Correlations with dementia , 1995, Annals of neurology.

[21]  A. Nath,et al.  HIV-1 coat protein gp120-induced increases in levels of intrasynaptosomal calcium , 1995, Brain Research.

[22]  R. Kerwin,et al.  Decreased expression of AMPA receptor messenger RNA and protein in AIDS: A model for HIV-associated neurotoxicity , 1995, Nature Medicine.

[23]  R. Brownstone,et al.  Human immunodeficiency virus type 1 tat activates non—N‐methyl‐D‐aspartate excitatory amino acid receptors and causes neurotoxicity , 1995, Annals of neurology.

[24]  P. Lantos,et al.  Neuronal pattern correlates with the severity of human immunodeficiency virus-associated dementia complex. Usefulness of spatial pattern analysis in clinicopathological studies. , 1996, The American journal of pathology.

[25]  J. Glass,et al.  Stereological analysis of cerebral atrophy in human immunodeficiency virus-associated dementia. , 1996, Journal of neuropathology and experimental neurology.

[26]  F. Scaravilli,et al.  HIV‐1 DNA in brains in AIDS and pre‐AIDS: Correlation with the stage of disease , 1996, Annals of neurology.

[27]  B. Chesebro,et al.  Quantitation of human immunodeficiency virus in brains of demented and nondemented patients with acquired immunodeficiency syndrome , 1996, Annals of neurology.

[28]  E. Masliah,et al.  Comparison of Two Quantitative Methods for the Evaluation of Neuronal Number in the Frontal Cortex in Alzheimer Disease , 1997, Journal of neuropathology and experimental neurology.

[29]  Peter R Mouton,et al.  Empirical assessment of synapse numbers in primate neocortex , 1997, Journal of Neuroscience Methods.

[30]  L. Thal,et al.  Neurocognitive impairment is an independent risk factor for death in HIV infection. San Diego HIV Neurobehavioral Research Center Group. , 1997, Archives of neurology.

[31]  E. Masliah,et al.  Glial cells in Alzheimer's disease: preferential effect of APOE risk on scattered microglia. , 1997, Gerontology.

[32]  E. Masliah,et al.  Dendritic injury is a pathological substrate for human immunodeficiency virus—related cognitive disorders , 1997, Annals of neurology.